Summit Therapeutics (SMMT) Other Operating Expenses (2017 - 2024)
Historic Other Operating Expenses for Summit Therapeutics (SMMT) over the last 6 years, with Q4 2024 value amounting to $205000.0.
- Summit Therapeutics' Other Operating Expenses rose 1452.51% to $205000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $205000.0, marking a year-over-year decrease of 9862.62%. This contributed to the annual value of $313000.0 for FY2024, which is 6873.13% down from last year.
- Summit Therapeutics' Other Operating Expenses amounted to $205000.0 in Q4 2024, which was up 1452.51% from -$264000.0 recorded in Q3 2024.
- Summit Therapeutics' 5-year Other Operating Expenses high stood at $15.0 million for Q2 2024, and its period low was -$264000.0 during Q3 2024.
- Over the past 3 years, Summit Therapeutics' median Other Operating Expenses value was $265000.0 (recorded in 2023), while the average stood at $3.1 million.
- Over the last 5 years, Summit Therapeutics' Other Operating Expenses had its largest YoY gain of 1452.51% in 2024, and its largest YoY loss of 19962.26% in 2024.
- Summit Therapeutics' Other Operating Expenses (Quarter) stood at $1.1 million in 2022, then plummeted by 84.2% to $179000.0 in 2023, then grew by 14.53% to $205000.0 in 2024.
- Its last three reported values are $205000.0 in Q4 2024, -$264000.0 for Q3 2024, and $15.0 million during Q2 2024.